Cumulative dose response study comparing HFA-134a albuterol sulfate and conventional CFC albuterol in patients with asthma. (Q46006614)

18 December 2017

title

Cumulative dose response study comparing HFA-134a albuterol sulfate and conventional CFC albuterol in patients with asthma. (English)

1 reference

18 December 2017

0 references

Ramsdell JW

1

1 reference

18 December 2017

Colice GL

series ordinal

2

1 reference

18 December 2017

Ekholm BP

series ordinal

3

1 reference

18 December 2017

Klinger NM

series ordinal

4

1 reference

18 December 2017

publication date

1 December 1998

1 reference

18 December 2017

Annals of Allergy, Asthma & Immunology

published in

1 reference

18 December 2017

volume

81

1 reference

18 December 2017

page(s)

593-599

1 reference

18 December 2017

issue

6

1 reference

18 December 2017

Clinical equivalence of a novel non-chlorofluorocarbon-containing salbutamol sulfate metered-dose inhaler and a conventional chlorofluorocarbon inhaler in patients with asthma

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962711-1

7 January 2021

The incidence of malignant melanoma in the United States: issues as we approach the 21st century

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962711-1

7 January 2021

Stratospheric sink for chlorofluoromethanes: chlorine atom-catalysed destruction of ozone

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962711-1

7 January 2021

The CFC-Ozone Issue: Progress on the Development of Alternatives to CFCs

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962711-1

7 January 2021

Issues surrounding MDI formulation development with non-CFC propellants

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962711-1

7 January 2021

Approaches and Challenges to Use Freon Propellant Replacements

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962711-1

7 January 2021

Model calculations of the relative effects of CFCs and their replacements on global warming

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962711-1

7 January 2021

Acute safety of the CFC-free propellant HFA-134a from a pressurized metered dose inhaler

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962711-1

7 January 2021

Cumulative dose-response study of non-CFC propellant HFA 134a salbutamol sulfate metered-dose inhaler in patients with asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962711-1

7 January 2021

Standardization of spirometry--1987 update. Statement of the American Thoracic Society

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962711-1

7 January 2021

A comparison of the Two One-Sided Tests Procedure and the Power Approach for assessing the equivalence of average bioavailability

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962711-1

7 January 2021

Assessment of airways, tremor and chronotropic responses to inhaled salbutamol in the quantification of beta 2-adrenoceptor blockade

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962711-1

7 January 2021

Beta-adrenoceptor responses to inhaled salbutamol in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962711-1

7 January 2021

The biochemical effects of high-dose inhaled salbutamol in patients with asthma.

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962711-1

7 January 2021

Dose-response comparison of broxaterol and salbutamol pressurized aerosols

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962711-1

7 January 2021

Bronchodilator, cardiovascular, and hypokalaemic effects of fenoterol, salbutamol, and terbutaline in asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962711-1

7 January 2021

The effect of maximal doses of formoterol and salbutamol from a metered dose inhaler on pulse rates, ECG, and serum potassium concentrations

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962711-1

7 January 2021

Dose response to inhaled salbutamol in chronic obstructive airways disease

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962711-1

7 January 2021

Lung bioavailability of chlorofluorocarbon free, dry powder and chlorofluorocarbon containing formulations of salbutamol

1 reference

https://api.crossref.org/works/10.1016%2FS1081-1206%2810%2962711-1

7 January 2021

10.1016/S1081-1206(10)62711-1

Identifiers

DOI

1 reference

18 December 2017

PubMed ID

9892032

1 reference

18 December 2017